|
|
Other links at Articles > Business of Medicine |
| 1. |
Genzyme Recalls Three Transplant Drug Lots: U.S. FDA
|
|
|
Genzyme Corp has voluntarily recalled three lots of Thymoglobulin, its injectable drug for transplant patients, after one lot failed a stability test, the U.S. Food and Drug Administration said on Thursday. Reuters Health Information
|
| 5. |
U.S. Inspects Few Foreign Drugmakers, Congress Told
|
|
|
U.S. regulators inspect few foreign makers of pharmaceutical ingredients and have no accurate count of how many companies supply the American market, a watchdog arm of Congress said on Thursday. Reuters Health Information
|
|
|
